tiprankstipranks
Trending News
More News >
Embecta Corporation (EMBC)
:EMBC
US Market

Embecta Corporation (EMBC) Earnings Dates, Call Summary & Reports

Compare
83 Followers

Earnings Data

Report Date
Aug 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.76
Last Year’s EPS
0.74
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 09, 2025
|
% Change Since: -9.62%
|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
While Embecta is making significant progress in debt reduction, employee engagement, and strategic partnerships for product expansion, the company faces challenges with declining revenues, particularly in the US and international markets, and tariff impacts on margins. The company has adjusted its revenue guidance downward but is implementing cost-saving measures to mitigate these issues.
Company Guidance
During Embecta Corp.'s fiscal second quarter 2025 earnings call, detailed financial guidance was provided for the remainder of the fiscal year. The company reported second-quarter revenue of $259 million, surpassing the previous guidance range of $250 million to $255 million, largely due to better than anticipated foreign exchange rates and constant currency performance. For fiscal year 2025, Embecta aims to reduce debt by approximately $110 million, with $60 million already achieved year-to-date. Despite challenges such as anticipated lower US volumes due to store closures at a specific retail pharmacy customer, the company is maintaining its as-reported revenue guidance due to favorable foreign exchange movements. Adjusted gross margin guidance was slightly lowered to account for incremental tariffs and reduced revenue expectations, yet adjusted operating and EBITDA margin guidance was raised due to effective cost management and restructuring initiatives. The restructuring plan, aimed at driving efficiencies, is expected to result in cost savings of $7 million to $8 million in the second half of fiscal 2025, with annualized savings projected around $15 million. The company remains committed to its strategic priorities of strengthening its core business, expanding its product portfolio, and increasing financial flexibility.
Exceeding Revenue Expectations
Second quarter revenue totaled $259 million, surpassing expectations of $250 million to $255 million due to strong constant currency performance and favorable foreign exchange rates.
Debt Reduction Progress
Embecta made a $27 million principal payment on its Term Loan B facility during the quarter and has reduced debt by approximately $60 million year-to-date, on track to achieve the goal of reducing debt by $110 million in fiscal 2025.
Employee Engagement and Recognition
Conducted a company-wide employee engagement survey, resulting in Embecta being certified as a Great Place to Work for 2025 in eight countries.
Strategic Partnerships in Product Expansion
Received several purchase orders from generic manufacturers to co-package pen needles, expanding into the generic GLP-1 drug market.
Operational and Financial Efficiency
Initiated a restructuring plan expected to save $7 million to $8 million in pre-tax costs during the second half of fiscal 2025.
---

Embecta Corporation (EMBC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EMBC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 07, 2025
2025 (Q3)
0.76 / -
0.74
May 09, 2025
2025 (Q2)
0.53 / 0.70
0.674.48% (+0.03)
Feb 06, 2025
2025 (Q1)
0.49 / 0.65
0.616.56% (+0.04)
Nov 26, 2024
2024 (Q4)
0.36 / 0.45
0.59-23.73% (-0.14)
Aug 09, 2024
2024 (Q3)
0.46 / 0.74
0.697.25% (+0.05)
May 09, 2024
2024 (Q2)
0.40 / 0.67
0.75-10.67% (-0.08)
Feb 09, 2024
2024 (Q1)
0.46 / 0.61
0.96-36.46% (-0.35)
Nov 21, 2023
2023 (Q4)
0.40 / 0.59
-0.3296.67% (+0.89)
Aug 08, 2023
2023 (Q3)
0.46 / 0.69
1.07-35.51% (-0.38)
May 12, 2023
2023 (Q2)
0.48 / 0.75
1.38-45.65% (-0.63)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

EMBC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 09, 2025
$13.30$11.97-10.00%
Feb 06, 2025
$18.00$17.53-2.61%
Nov 26, 2024
$14.14$18.35+29.77%
Aug 09, 2024
$13.92$14.94+7.33%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Embecta Corporation (EMBC) report earnings?
Embecta Corporation (EMBC) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
    What is Embecta Corporation (EMBC) earnings time?
    Embecta Corporation (EMBC) earnings time is at Aug 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EMBC EPS forecast?
          EMBC EPS forecast for the fiscal quarter 2025 (Q3) is 0.76.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis